TickerFactsScreenerDevelopers

FATE THERAPEUTICS INC (FATE) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $2.0K2012: $709.0K2013: $244.0K2014: $882.0K2015: $1.50M2016: $457.0K2017: $1.73M2018: $2.30M2019: $7.39M2020: $4.93M2021: $50.70M2022: $35.57M2023: $6.15M2024: $730.0K2025: $5.95M$5.95M
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$5.95M+715.5%
2024$730.0K-88.1%
2023$6.15M-82.7%
2022$35.57M-29.9%
2021$50.70M+928.1%
2020$4.93M-33.3%
2019$7.39M+221.1%
2018$2.30M+33.5%
2017$1.73M+277.5%
2016$457.0K-69.5%
2015$1.50M+69.8%
2014$882.0K+261.5%
2013$244.0K-65.6%
2012$709.0K+35350.0%
2011$2.0K—